They develop speech-based cognitive testing tools that are automated, low-burden, and usable on any smart device, designed to scale access to early Alzheimer's detection worldwide, especially in underserved communities. Their solutions include the Novoic Storyteller, an automated audio-verbal assessment, and the Novoic Dashboard for managing digital screening and monitoring at scale.

Their advanced AI models aim for better results in early detection, differential diagnosis, and robustness, leveraging large proprietary datasets and clinical trial validation. The company prioritizes data privacy, security, and quality management with strong HIPAA/GDPR compliance and secure software design.

They collaborate with 50+ medical institutions and participate in clinical trials to refine their technologies. Their products support scalable, AI-assisted triage, monitoring, and data analytics to improve patient outcomes in Alzheimer's research and care.